Selvi Pharmaceuticals Private Limited
About Selvi Pharmaceuticals Private Limited
Data last updated:
Selvi Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 22 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2016PTC111076. Its GSTIN is 36AAXCS3611B1ZD (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Silveru Sandeep Kumar and Rajender Silveru.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 9 – 9 – 147/1 Reddy Colony Champapet Saidabad, Hyderabad, Telangana, India – 500059.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.88 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹49,524 (net margin 2.3%) and EBITDA of ₹71,118 (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Selvi Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address9 – 9 – 147/1 Reddy Colony Champapet Saidabad, Hyderabad, Telangana, India – 500059
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Selvi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Selvi Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Selvi Pharmaceuticals Private Limited, buy the company report.
Financials of Selvi Pharmaceuticals Private Limited
FY 2025 filings availableSelvi Pharmaceuticals Private Limited reported revenue of ₹21.88 Lakh (down 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 20% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹71,118 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹49,524 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Selvi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Selvi Pharmaceuticals Private Limited
Selvi Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajender Silveru | Additional Director | 13 May 2019 | 7 Years 5 Months | Current |
| Ravinder Silveru | Additional Director | 19 Dec 2018 | 7 Years 10 Months | Current |
| Silveru Sandeep Kumar | Director | 22 Jul 2016 | 10 Years 3 Months | Current |
Auditor
Selvi Pharmaceuticals Private Limited is audited by RAJGOLLAPPAGARI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJGOLLAPPAGARI | FY 2017 | 219531 |
Shareholding
The shareholding of Selvi Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Selvi Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Selvi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Selvi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Selvi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAXCS3611B1ZD | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Selvi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Selvi Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Rajender Silveru was appointed as Additional Director on 13 May 2019.
Frequently asked questions
Selvi Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in other wholesale, within the trading industry. It was incorporated on 22 July 2016 (10+ years old) and is registered under CIN U74999TG2016PTC111076.
Selvi Pharmaceuticals has 3 current directors:
- Rajender Silveru - Additional Director
- Ravinder Silveru - Additional Director
- Silveru Sandeep Kumar - Director
The latest financial statements of Selvi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Selvi Pharmaceuticals is 36AAXCS3611B1ZD, registered in Telangana.
The CIN (Corporate Identification Number) of Selvi Pharmaceuticals is U74999TG2016PTC111076. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Selvi Pharmaceuticals was incorporated on 22 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Rajender Silveru was appointed as Additional Director on 13 May 2019. Chandra Shekar Siliveru ceased to be Director on 20 Dec 2018. Ravinder Silveru was appointed as Additional Director on 19 Dec 2018. Selvi Pharmaceuticals has 4 board changes on record in total.
The registered office of Selvi Pharmaceuticals is at 9 – 9 – 1471 Reddy Colony Champapet Saidabad, Hyderabad, Telangana, India – 500059.
Selvi Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Selvi Pharmaceuticals is compliant as of 13 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
